ACCESSION: MSBNK-SMB_Measured-HSA001P0127000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'19_posi_6123': {'bp': 399912.0, 'sum': 1461131.0}, '17_posi_6089': {'bp': 357468.0, 'sum': 1300565.0}, '16_posi_6067': {'bp': 352952.0, 'sum': 1293633.0}, '12_posi_6045': {'bp': 336616.0, 'sum': 1272213.0}, '14_posi_6047': {'bp': 317145.0, 'sum': 1182230.0}, '8_posi_6047': {'bp': 310184.0, 'sum': 1160147.0}, '10_posi_6045': {'bp': 286578.0, 'sum': 1102980.0}, '5_posi_6022': {'bp': 275472.0, 'sum': 1042530.0}, '4_posi_6046': {'bp': 267000.0, 'sum': 1058319.0}, '3_posi_6024': {'bp': 259304.0, 'sum': 1004483.0}, '11_posi_6066': {'bp': 251920.0, 'sum': 994482.0}, '6_posi_6067': {'bp': 234981.0, 'sum': 964942.0}, '9_posi_6087': {'bp': 227481.0, 'sum': 925730.0}}
COMMENT: RETENTION_TIME_STDEV 0.056
COMMENT: PRECURSOR_M/Z_RAW 127.097666
COMMENT: PRECURSOR_M/Z_STDEV 0.000038
COMMENT: PRECURSOR_IN_MS1 mz 127.097830; int 136.341; delta(ppm) 1.388164
COMMENT: PROPOSED_CHARGE_STATE +1; mz 128.101290; int 7.292; cor 0.636
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.056; C5H10N4; [M+H]+; delta(ppm) 0.055516
COMMENT: PROPOSED_MF MS-FINDER 2.995; C5H10N4; [M+H]+; delta(ppm) 0.048935
COMMENT: PROPOSED_MF SIRIUS5_Sirius 21.086; C5H10N4; [M+H]+; delta(ppm) 0.048935
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H10N4; [M+H]+; delta(ppm) 0.048935
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.721; C5H10N4; [M+H]+; delta(ppm) 0.048935
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.107; C7H12NO; [M+H]+; delta(ppm) -10.514971
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H10N4; [M+H]+; delta(ppm) 0.048935
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.043; MDLFQCVYROBFIW-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.875; ZEKBKTMMBLWNGK-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.684; IXXJEYNOJZNYBD-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.454; FZSOHMVWLBLDDI-UHFFFAOYSA-N; [M+H]+; 2-(5-methyl-1H-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; KREZLVQDKZOBGP-UHFFFAOYSA-N; [M+H]+; (1-ethylpyrazol-3-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.913; IRAYOVGHEWBMFZ-UHFFFAOYSA-N; [M+H]+; 3-(2H-triazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.907; HIPCZDJJSWENJP-UHFFFAOYSA-N; [M+H]+; (3-methylimidazol-4-yl)methylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.874; KJPISRZKUHMHMC-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-1-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.831; XGQWLORBOSWDGW-UHFFFAOYSA-N; [M+H]+; 3-(1H-1,2,4-triazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.806; MRAPXKXFUVKPFR-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.783; UVTCBDINHWFZES-UHFFFAOYSA-N; [M+H]+; [1-(azidomethyl)cyclopropyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.775; ZTZDXHFMAKRNMX-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-triazol-1-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.774; OCXIKYJPCILJLE-UHFFFAOYSA-N; [M+H]+; 1-(2-methyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.772; SEDFRMHLJGECEU-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1-methyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.766; LWZQTTFPSLUYQX-UHFFFAOYSA-N; [M+H]+; 2-(2H-triazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.765; SFYKXXAKLXIRDR-UHFFFAOYSA-N; [M+H]+; 4-propyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.765; CKEOLAXSCNIKJR-UHFFFAOYSA-N; [M+H]+; 4-propan-2-yl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.764; AERFFVLJKPEURK-SCSAIBSYSA-N; [M+H]+; (1R)-1-(3-methyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.764; RLJVJOHKWIRKKJ-UHFFFAOYSA-N; [M+H]+; 2-(1H-1,2,4-triazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.763; OUROGIJRFJQLAW-UHFFFAOYSA-N; [M+H]+; 2-(4-methyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.760; FTILWFNDSQHZBI-UHFFFAOYSA-N; [M+H]+; 2-(1-methyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.759; JMKNFBHEYCDIRE-UHFFFAOYSA-N; [M+H]+; 2-propan-2-yltriazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.754; SJWJIKMZQXUVSC-UHFFFAOYSA-N; [M+H]+; 2-(4-methyltriazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.748; MYXSAVAFEFCDKG-UHFFFAOYSA-N; [M+H]+; 1-propan-2-yl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.745; IQVSUNIKPGWHEJ-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.743; OTANTFOQCVGSJL-UHFFFAOYSA-N; [M+H]+; (4-ethyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.742; DAVBTDJVFQZWRO-UHFFFAOYSA-N; [M+H]+; 1-(4-methyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.739; LNTHUBFWDIZBAA-UHFFFAOYSA-N; [M+H]+; 1-propan-2-yltriazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.735; DWCRLOOUYKVCHQ-UHFFFAOYSA-N; [M+H]+; 1-(1-methyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.731; XWBQALHNZUKXHB-UHFFFAOYSA-N; [M+H]+; 2-(1-methyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.728; CEHWOQJCKWKFJD-UHFFFAOYSA-N; [M+H]+; (4,5-dimethyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.725; RVFCWTOXJWOHRS-GSVOUGTGSA-N; [M+H]+; (1R)-1-(5-methyl-1H-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.713; DSCMUEBXUWVBIT-UHFFFAOYSA-N; [M+H]+; (3-ethyl-1H-1,2,4-triazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.708; SXJKZCLYUDXHSD-UHFFFAOYSA-N; [M+H]+; 3-(triazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.689; LIUXPNMASXXMLO-UHFFFAOYSA-N; [M+H]+; (2-ethyltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.686; PKSJRBYCXQPZHB-UHFFFAOYSA-N; [M+H]+; 4-azidopiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.679; KWCCAAOJVJJWPQ-UHFFFAOYSA-N; [M+H]+; (1-ethyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.661; GUYRJILQXBQXHO-UHFFFAOYSA-N; [M+H]+; 5-ethyl-2-methyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.624; MYGYPYCRGWRUJQ-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-methyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.622; NDYMKGVUANYRJD-UHFFFAOYSA-N; [M+H]+; 3-azidopiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.619; LALQVQUNUJNEST-RXMQYKEDSA-N; [M+H]+; (2R)-2-(azidomethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.613; JXYKNUJAOXDKLK-UHFFFAOYSA-N; [M+H]+; 3-(azidomethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.511; LHMZYMGVGMFPFJ-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(5-methyl-1H-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.309; CTCSNNYGCPZWSQ-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1-methyltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.289; HOYRTZULOHVTMN-UHFFFAOYSA-N; [M+H]+; N-methyl-2-(1,2,4-triazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.278; VXKNGTCDCIRERB-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(4-methyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.266; XFRKAZBZVVTALF-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(2-methyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -153.696; PDWGQCUSLDPUFM; [M+H]+; 2-Aminohistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.011; MDLFQCVYROBFIW; [M+H]+; 3-Amino-5-isopropyl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.157; FZSOHMVWLBLDDI; [M+H]+; Oprea1_137355
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.191; CEHWOQJCKWKFJD; [M+H]+; (4,5-dimethyl-4H-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.908; OTANTFOQCVGSJL; [M+H]+; (4-ethyl-4H-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.344; KJPISRZKUHMHMC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.878; MRAPXKXFUVKPFR; [M+H]+; 3-(triazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.208; PDWGQCUSLDPUFM; [M+H]+; 2-Aminohistamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.474; PDWGQCUSLDPUFM; [M+H]+; 5-(2-aminoethyl)-1H-imidazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -149.208; FZSOHMVWLBLDDI; [M+H]+; 2-(5-Methyl-4H-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -161.080; MDLFQCVYROBFIW; [M+H]+; 5-Isopropyl-4H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.661; SEDFRMHLJGECEU; [M+H]+; 5-Ethyl-1-methyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -172.071; KJPISRZKUHMHMC; [M+H]+; 4-(aminomethyl)-1-methyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -174.148; SJWJIKMZQXUVSC; [M+H]+; 2-(4-Methyl-1h-1,2,3-triazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -177.075; MRAPXKXFUVKPFR; [M+H]+; 3-(1H-1,2,3-triazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.961; GUYRJILQXBQXHO; [M+H]+; 5-ethyl-2-methyl-2H-[1,2,4]triazol-3-ylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -184.486; LIUXPNMASXXMLO; [M+H]+; (2-ethyl-2H-1,2,3-triazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -190.303; JMKNFBHEYCDIRE; [M+H]+; 2-Isopropyl-2H-1,2,3-triazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.136; PDWGQCUSLDPUFM; [M+H]+; 5-(2-aminoethyl)-1H-imidazol-2-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H11N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 12.142
MS$FOCUSED_ION: PRECURSOR_M/Z 127.097829
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004r-5900000000-ca1b610762f4538dc8d5
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495350 21.7296 56.050167 1.2132 3.76 0.2517 12 f{C3H6N1}/1.06ppm,p-C2H5N3
  68.0495005 84.4388 68.050132 0.8523 9.20 0.9066 13 f{C4H6N1}/0.37ppm,p-C1H5N3
  70.0650185 13.1103 70.065638 2.0981 3.40 -0.1152 10 f{C4H8N1}/-1.53ppm,p-C1H3N3
  83.0604446 14.4460 83.060948 2.3718 2.45 0.5315 12 f{C4H7N2}/0.84ppm,p-C1H4N2
  84.0681198 36.5063 84.068612 1.0230 7.95 0.0385 13 f{C4H8N2}/-0.95ppm,p-C1H3N2
  85.0760223 999.0000 85.076502 0.3409 14.45 0.9780 13 f{C4H9N2}/-0.03ppm,p-C1H2N2
  86.0600402 19.0243 86.060507 1.2201 4.92 -0.1813 13 ?
  97.0760481 179.6761 97.076393 0.4430 25.31 0.5824 13 f{C5H9N2}/0.24ppm,p-H2N2
  99.0917047 31.1392 99.092034 1.4936 7.77 0.4396 13 f{C5H11N2}/0.30ppm,p-N2
  110.0712820 443.3800 110.071508 0.3361 21.69 0.9341 13 f{C5H8N3}/0.08ppm,p-H3N1
  127.0503146 56.9627 127.050328 1.1413 11.85 -0.0385 13 ?
  127.0867974 597.6455 127.086810 0.9206 99.82 0.0879 13 ?
  127.0978991 976.3185 127.097911 0.9520 36.27 1.0000 13 f{C5H11N4}/0.60ppm,p
  127.1062708 278.8173 127.106283 0.6923 43.78 0.5549 13 ?
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  56.049535 21.73 21
  68.049500 84.44 84
  70.065018 13.11 13
  83.060445 14.45 14
  84.068120 36.51 36
  85.076022 999.00 999
  86.060040 19.02 19
  97.076048 179.68 179
  99.091705 31.14 31
  110.071282 443.38 443
  127.050315 56.96 56
  127.086797 597.65 597
  127.097899 976.32 976
  127.106271 278.82 278
//
